| Endologix develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. Co.'s products are designed for the endovascular treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: endovascular aneurysm repair (EVAR); or endovascular aneurysm sealing (EVAS), Co.'s solution for sealing the aneurysm sac while maintaining blood flow. Co.'s EVAR products include the AFX® Endovascular AAA System, the VELA® Proximal Endograft, and the Ovation® Abdominal Stent Graft System. Co.'s EVAS product is the Nellix® Endovascular Aneurysm Sealing System. The ELGX YTD return is shown above.
The YTD Return on the ELGX YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ELGX YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ELGX YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.